The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJDS.L Regulatory News (JDS)

  • There is currently no data for JDS

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

5 Mar 2020 09:21

RNS Number : 1288F
Jardine Matheson Hldgs Ltd
05 March 2020
 

Jardine Matheson Holdings Limited

Directorate Change

 

Jardine Matheson Holdings Limited (the 'Company') announces that, with effect from 15th June 2020, the roles of Executive Chairman and Managing Director, which have been held on a combined basis by Ben Keswick since December 2018, will revert to being separate roles.

 

Ben Keswick will remain as Executive Chairman and John Witt, currently Group Finance Director, will take on the role of Managing Director.

 

John joined Jardines in 1993 and held a range of senior roles across the Group's core businesses and geographies, including as chief financial officer of Hongkong Land and Mandarin Oriental, before being appointed to the Jardine Matheson Board in 2016.

 

John will also be a director of Jardine Strategic Holdings Limited and the Group's listed subsidiaries, Hongkong Land Holdings Limited, Dairy Farm International Holdings Limited and Mandarin Oriental International Limited. He will also continue to be a commissioner of Astra and chairman of the Astra Excom.

 

Graham Baker will replace John as Group Finance Director and will join the Group on 1st June 2020 from Smith + Nephew in the United Kingdom, where he has been a board member and chief financial officer since March 2017. Graham will join the Board of the Company.

 

Prior to joining Smith + Nephew, Graham worked for 20 years for AstraZeneca PLC in a range of senior roles in the UK and internationally, including in Japan and Singapore, and then as chief financial officer of generic pharmaceuticals company Alvogen.

 

Commenting on the changes, Ben Keswick said:

"I am confident that these appointments will strengthen and enhance the effectiveness of the Group's leadership as we respond to the challenges and opportunities we face in positioning Jardines for continuing long term success."

 

- end -

 

For further information please contact

 

Investor enquries:

Jonathan Lloyd

Jardine Matheson Limited

 

(852) 2843 8223

 

Media enquiries:

Brunswick

Tom Burns

 

(44) 207 404 5959

David Ashton

(852) 3512 5063

 

This and other Group announcements can be accessed at www.jardines.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOAUPUBAWUPUURA
Date   Source Headline
1st Aug 201910:16 amRNSHalf-year Report
1st Aug 201910:16 amRNSHalf-year Report
1st Aug 201910:16 amRNSHalf-year Report
31st Jul 201910:33 amRNSFirst Half 2019 Results of PT Hero
30th Jul 201910:49 amRNSPT Astra Intl Tbk - 2019 First Half Fin Statements
4th Jul 201910:20 amRNSNotice of 2019 Half-Yearly Results
28th Jun 201911:04 amRNSShares Purchase
25th Jun 201911:28 amRNSShares Purchase
20th Jun 201911:59 amRNSShares Purchase
17th Jun 201910:59 amRNSShares Purchase
14th Jun 201911:13 amRNSShares Purchase
13th Jun 20197:00 amRNSShares Purchase
11th Jun 201910:47 amRNSShares Purchase
6th Jun 201912:23 pmRNSShares Purchase
31st May 201910:14 amRNSTotal Voting Rights
29th May 201911:06 amRNSShares Purchase
21st May 201911:19 amRNSShares Purchase
15th May 201910:14 amRNSDirector/PDMR Shareholding
10th May 201910:12 amRNSAdditional Listing
9th May 20194:34 pmRNSDirectorate Change
9th May 20194:33 pmRNSAGM Statement
9th May 20194:24 pmRNSResult of AGM
9th May 201912:33 pmRNSInterim Management Statement
9th May 201912:32 pmRNSInterim Management Statement
8th May 201912:36 pmRNSInterim Management Statement
8th May 201912:36 pmRNSInterim Management Statement
8th May 201912:32 pmRNSInterim Management Statement
2nd May 201910:20 amRNSDividend
29th Apr 201910:49 amRNSFirst Quarter 2019 Results of PT Hero
26th Apr 201910:35 amRNSJC&C 2019 First Quarter Financial Statements
24th Apr 201911:09 amRNSPT Astra 2019 First Quarter Financial Statements
18th Apr 201910:58 amRNSDividend
4th Apr 201910:13 amRNSAnnual Financial Report
27th Mar 20199:13 amRNSCirc re. Scrip Dividend Scheme
19th Mar 20199:58 amRNSShares Purchase
15th Mar 201910:05 amRNSShares Purchase
13th Mar 201910:05 amRNSShares Purchase
11th Mar 201910:32 amRNSShares Purchase
6th Mar 201910:14 amRNSShares Purchase
4th Mar 201910:33 amRNSShares Purchase
1st Mar 201910:49 amRNSShares Purchase
28th Feb 20199:25 amRNS2018 Preliminary Announcement of Results
28th Feb 20199:23 amRNS2018 Preliminary Announcement of Results
28th Feb 20199:19 amRNSFull Year 2018 Results of PT Hero
28th Feb 20199:18 amRNS2018 PRELIMINARY ANNOUNCEMENT OF RESULTS
28th Feb 20199:06 amRNS2018 PRELIMINARY ANNOUNCEMENT OF RESULTS
28th Feb 20199:06 amRNS2018 Preliminary Announcement of Results
27th Feb 20199:50 amRNSJC&C 2018 Financial Statements
27th Feb 20199:41 amRNSPT Astra Intl TBK - 2018 FY Financial Statements
30th Jan 20199:17 amRNSNotice of 2018 Final Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.